SciSparc : MitoCareX Update - Form 6-K -March 13, 2024 at 09:09 am EDT
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K Report of Foreign Private Issuer ...
Source: marketscreener.com
Oz Adler News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Oz Adler. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Oz Adler Today - Breaking & Trending Today
SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing
The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment initiation TEL AVIV, Israel, Feb. 29,...
Source: marketscreener.com
SciSparc Delivers Treatment for Autism Spectrum Disorder
The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment...
Source: globenewswire.com
What's Going On With Psychedelic Drug-Developers SciSparc And Clearmind Stock? - SciSparc (NASDAQ:SPRC)
SciSparc Ltd. and Clearmind Medicine Inc. shares are trading higher Tuesday after the companies announced the submission of three international patent applications as part of the ongoing collaboration between the companies.
Source: benzinga.com
SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in ...
The clinical trial for SCI-210 will be conducted in Israel, after which the company aims to move forward with the commercialization process of SCI-210 first in the Israeli market
Source: eagletribune.com